Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Saccharomyces Boulardii CNCM I-745 in the Treatment of Small Intestinal Bacterial Overgrowth in Patients Suffering From Irritable Bowel Syndrome With Diarrhea

NCT04627337 is registered in ClinicalTrials.gov with Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno as lead sponsor.

NCT NCT04627337
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04627337 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Saccharomyces Boulardii CNCM I-745 in the Treatment of Small Intestinal Bacterial Overgrowth in Patients Suffering From Irritable Bowel Syndrome With Diarrhea
Lead sponsor
Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno
Phase
Phase 4
Overall status
Completed
Start date
February 1, 2017
Completion date
August 31, 2018
Enrollment
71 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

irritable bowel syndrome